Clinical Trials Directory

Trials / Terminated

TerminatedNCT01100658

Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors

Effects of Methylphenidate on Neuropsychological Functioning in Children With Attention Deficits Secondary to Childhood Cancer

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
1 (actual)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
8 Years – 17 Years
Healthy volunteers
Not accepted

Summary

While neurocognitive impairments in attention, memory and executive functioning are commonly reported sequelae of childhood leukemia and brain tumors, studies have only recently begun to examine the treatment of attention deficits in this population. Numerous studies have examined the effectiveness of methylphenidate in the treatment of children with attention deficit hyperactivity disorder (ADHD). However, the effectiveness of this medication for improving attention and behavioral functioning in children with medical illnesses or brain injury are less clear. Patients will be randomized to receive one week of Metadate CD (a controlled release form of methylphenidate, similar to Ritalin) and one week of placebo in a double-blind fashion.

Conditions

Interventions

TypeNameDescription
DRUGMethylphenidate1 capsule each day for 1 week, .3 mg/kg dose.
DRUGPlacebo1 capsule per day for 1 week.

Timeline

Start date
2010-05-01
Primary completion
2010-11-01
Completion
2010-11-01
First posted
2010-04-09
Last updated
2015-03-27
Results posted
2011-11-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01100658. Inclusion in this directory is not an endorsement.